Brain ERP components predict which individuals progress to Alzheimer's disease and which do not

Abstract Predicting which individuals will progress to Alzheimer's disease (AD) is important in both clinical and research settings. We used brain Event-Related Potentials (ERPs) obtained in a perceptual/cognitive paradigm with various processing demands to predict which individual Mild Cogniti...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of aging Vol. 32; no. 10; pp. 1742 - 1755
Main Authors Chapman, Robert M, McCrary, John W, Gardner, Margaret N, Sandoval, Tiffany C, Guillily, Maria D, Reilly, Lindsey A, DeGrush, Elizabeth
Format Journal Article
LanguageEnglish
Published London Elsevier Inc 01.10.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Predicting which individuals will progress to Alzheimer's disease (AD) is important in both clinical and research settings. We used brain Event-Related Potentials (ERPs) obtained in a perceptual/cognitive paradigm with various processing demands to predict which individual Mild Cognitive Impairment (MCI) subjects will develop AD versus which will not. ERP components, including P3, memory “storage” component, and other earlier and later components, were identified and measured by Principal Components Analysis. When measured for particular task conditions, a weighted set of eight ERP component_conditions performed well in discriminant analysis at predicting later AD progression with good accuracy, sensitivity, and specificity. The predictions for most individuals (79%) had high posterior probabilities and were accurate (88%). This method, supported by a cross-validation where the prediction accuracy was 70–78%, features the posterior probability for each individual as a method of determining the likelihood of progression to AD. Empirically obtained prediction accuracies rose to 94% when the computed posterior probabilities for individuals were 0.90 or higher (which was found for 40% of our MCI sample).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Currently at Springer Publishing Company.
Currently at Joint Doctoral Program in Clinical Psychology at San Diego State University / University of California at San Diego.
Currently at Department of Pharmacology and Experimental Therapeutics at Boston University.
Currently at Chicago College of Osteopathic Medicine at Midwestern University.
ISSN:0197-4580
1558-1497
DOI:10.1016/j.neurobiolaging.2009.11.010